Last updated: 2026-10-09 20:20:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
NeuroOne Medical Technologies Corporation (NMTC) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $1.12, with a market capitalisation of $10.11M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.96 to $6.54. This page covers its latest market performance, valuation, price trends and company information.
$10.11M | |
$1.07 | |
$47.82 | |
$0.96 | |
$1.08 | |
77.02K | |
338.56K | |
-- | |
$6.54 | |
$0.96 | |
-- | |
-- |
NeuroOne Medical Technologies Corporation (NMTC) is trading at $1.12 in after-hours trading as of 2026-10-09 19:59:37, up 3.89% ($0.04) from the regular-session close of $1.08.
After-hours trading shows how investors are pricing NMTC after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, NeuroOne Medical Technologies Corporation (NMTC) moved from $1.03 to $1.12, representing a gain of 8.25% ($0.08).
The stock traded between $0.96 and $1.35 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 278.37 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 2.8%
NMTC is currently trading at $1.12, placing it 2.8% of the way from its 52-week low of $0.96 to its 52-week high of $6.54. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 18 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of NeuroOne Medical Technologies Corporation (NMTC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.